« Return to News | Ethics/Regulatory | Drug Sponsors

Family medicine residencies reject pharma relationships

Tuesday, March 29, 2011 10:28 AM

Family medicine resident programs in the U.S. have limits on drug industry interaction with doctors, and several shun doctor-company relationships altogether.

Those are the results of a survey by Georgetown University Medical Center and the American Medical Student Association, according to Medical Marketing & Media.

A 2008 survey of directors or coordinators of all 460 accredited family medicine residency programs drew responses from 62.2%. Over 52% said they refused drug samples, and industry gifts or food were declined by 48.6%. Sixty-eight percent said they did not allow industry-sponsored residency activities, and 44.1% denied industry access to students and residents at the family medicine center. Seventy-five residencies, 26.2% of those responding, were designated as “pharma-free.”

In contrast, a 1992 survey showed 90% of family medicine residencies allowed industry support, said Georgetown's Dr. Adriane Fugh-Berman, M.D., who is also director of drug industry watchdog PharmedOut.

“Family medicine is leading the way in closing the door on pharma” said Dr. Fugh-Berman in a statement. “Our survey allows for comments, so we know that some residency programs report recent changes in plans or practices to limit industry interaction. Although some faculty and some residents are opposed to these limits, it's clear that industry influence on family medicine residencies is waning.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.